Overview

Study Determining Gastric-Retentive and Modified Release Properties of Prototype Capsules in Healthy Subjects

Status:
Terminated
Trial end date:
2017-09-18
Target enrollment:
Participant gender:
Summary
To assess how long modified release (MR) memantine hydrochloride prototype capsule formulations stay in the stomach as determined by magnetic resonance imaging (MRI).
Phase:
Early Phase 1
Details
Lead Sponsor:
Lyndra Inc.
Treatments:
Memantine